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A B S T R A C T
Divalent copper and iron cations have been acknowledged for their catalytic roles in physiological processes
critical for homeostasis maintenance. Being redox-active, these metals act as cofactors in the enzymatic reactions
of electron transfer. However, under pathophysiological conditions, owing to their high redox potentials, they
may exacerbate stress-induced injury. This could be particularly hazardous to the liver - the main body reservoir
of these two metals. Surprisingly, the involvement of Cu and Fe in liver pathology still remains poorly under-
stood. Hypoxic stress in the tissue may act as a stimulus that mobilizes these ions from their hepatic stores,
aggravating the systemic injury. Since ischemia poses a serious complication in liver surgery (e.g. transplanta-
tion) we aimed to reveal the status of Cu and Fe via spectroscopic analysis of mouse ischemic liver tissue. Herein,
we establish a novel non-surgical model of focal liver ischemia, achieved by applying light locally when a
photosensitizer is administered systemically. Photodynamic treatment results in clear-cut areas of the ischemic
hepatic tissue, as confirmed by ultrasound scans, mean velocity measurements, 3D modelling of vasculature and
(immuno)histological analysis. For reference, we assessed the samples collected from the animals which de-
veloped transient systemic endotoxemic stress induced by a non-lethal dose of lipopolysaccharide. The electron
paramagnetic resonance (EPR) spectra recorded in situ in the liver samples reveal a dramatic increase in the level
of Cu adducts solely in the ischemic tissues. In contrast, other typical free radical components of the liver EPR
spectra, such as reduced Riske clusters are not detected; these differences are not followed by changes in the
blood EPR spectra. Taken together, our results suggest that local ischemic stress affects paramagnetic species
containing redox-active metals. Moreover, because in our model hepatic vascular flow is impaired, these effects
are only local (confined to the liver) and are not propagated systemically.
1. Introduction
Local circulation failure results in tissue restricted blood flow (hy-
poperfusion), followed by a shortage of nutrients and oxygen. In turn, a
decreased level of oxygen (hypoxia) drives ischemic stress with further
disruption in the tissue redox balance. This is particularly hazardous in
organs with intensive oxygen metabolism such as the brain or the heart
[1], where ischemic tissue injury may lead to necrotic cell death and
development of infarction. Nevertheless, organs with somewhat lower
oxygen requirements, such as the liver [1], may also suffer from
hypoperfusion-related cellular damage, e.g. hypoxic hepatitis [2]. The
pathogenesis of hepatic tissue injury could be even more complex since
the liver serves as the main body reservoir of redox-active transition
metal ions such as copper and iron [3–5]. Owing to their inherent
flexibility in the oxidation state and the type and number of molecular
bonds formed (ligancy), these metals act as static cofactors within
protein active sites in vivo [6]. On the other hand, redox-active transi-
tion metal ions may catalyze the formation of harmful free radicals (e.g.
lipid-based radicals) in situ in the cell. These reactive species are gen-
erated in the pathophysiological processes of oxidation/reduction
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fueled by the Fenton or Haber-Weiss reactions [7–9], predominantly in
an environment of cellular membranes. In such a nonpolar environment
the generation of lipid-based reactive species is dramatically ac-
celerated by divalent metal ions, especially Fe(II) [10] and Cu(II) [11].
In order to prevent the potential metal toxicity from being exacerbated,
the availability of redox-active transition metals is regulated in the
cells. Significantly, recent studies on transition elements in biological
systems have highlighted a regulatory role of iron in a type of cell death
called ferroptosis, characterized by the accumulation of lipid peroxides
[10,12]. However, the exact molecular mechanism that explains the
role of Fe in this process has yet to be described [13].
In humans, both Cu and Fe are essential micronutrients, therefore a
balanced supply of them in a diet is of critical importance for devel-
opment and health. After intestinal absorption, these cations are
transported to the liver, where they may be stored in hepatocytes as
well as other cell types [14]. A normal human liver stores 15–55 μg Cu
per 1 g of its dry weight [15], whereas its Fe content ranges from 0.2 to
2 mg per 1 g of hepatic dry weight [16]. These values vary between
men and women and may depend on hormone levels (e.g. Fe content in
the liver was found to be higher in post-menopausal women). Im-
portantly, cases of Fe overdose in children have been reported after
excessive intake of dietary supplements - brightly colored and sugar-
coated, and thus often perceived as sweets by children [17]. What is
more, the accumulation of redox-active transition metals can be ele-
vated under certain genetic conditions that affect metal excretion by the
liver cells. For instance, impaired release of Cu ions from the hepato-
cytes and thus its pathological accumulation in the liver results in se-
vere organ toxicity implicated into the mechanism of Wilson's disease
[4,5,18]. Another example of a metal-related pathology is hemochro-
matosis associated with excessive accumulation and toxicity of Fe, also
in the liver [19]. However, the hepatotoxicity of copper/iron is not
limited to sufferers of these relatively rare diseases. Redox-active
transition metals have been reported to aggravate other liver patholo-
gies such as ischemia/reperfusion injury [20], and others. Finally, as
common environmental pollutants, Cu and/or Fe may affect a much
larger number of people. Because of their accumulation in the mi-
tochondrial membranes, they may induce peroxidation of membrane
lipids, thus causing severe disturbances in respiratory chain and im-
pairing normal mitochondrial functions [11,21]. This raises serious
concerns over the adverse effects of both micronutrients we are exposed
to in our daily diet, and the transition metal ions that have already
accumulated in the liver. Normally being essential for good health,
these metals, when in excess, may exacerbate certain pathophysiolo-
gical conditions. In the case of ischemia/reperfusion injury, they could
also affect the outcomes of life-saving therapies such as liver trans-
plantation. Therefore, diagnosis based on a detailed description of the
content of transition metal and their redox state in situ in the liver
specimens would provide data of predictive and/or prognostic value.
This could be achieved by the use of electron paramagnetic/spin
resonance (EPR/ESR) spectroscopy, which detects the paramagnetic
species characterized by the presence of unpaired electrons. EPR
spectroscopy may also be used to draw conclusions regarding non-metal
paramagnetic molecules such as NO, an inflammatory mediator and
blood flow regulator produced by nitric oxide synthases (NOS).
Importantly, transition metal ions may bind to specific sites on NOS,
and thus affect its enzymatic activity [22]; however, among the metals
that have been studied only non-heme iron increases NOS activity [22].
Other divalent transition metals are unable to activate NOS; in fact, for
Cu(II), an inhibitory effect has been demonstrated [22]. These inter-
actions with NOS, however, might be perceived as a double-edge sword.
NO is a very potent vasodilator, which, when generated locally, facil-
itates vascular drainage of toxic species produced when the tissue is
damaged [23]. Since ischemic liver injury affects hepatic micro-
vasculature and impairs the function of endothelial NOS (eNOS), it
causes a decline in the local production of NO [23]. In such a case, the
inhibitory effect of transition metals on eNOS becomes even more
pronounced, further exacerbating tissue damage. On the other hand,
upon restoration of blood flow, NO reacts with oxygen, which yields
toxic reactive nitrogen species, resulting in the reperfusion injury.
However, the detailed mechanisms of in vivo NO-metal ion interactions,
and their impact on human health, are yet to be described. This has
prompted us to investigate NO-redox-active transition metal tissue
homeostasis in the normal versus pathological liver and in the blood, in
animal model. Two mouse models of liver stress were used: (i) the
photodynamic stress model developed by us [24], and (ii) the en-
dotoxemic stress model. In the former model, a light-activated pro-drug
is administered systematically, after which red light is applied locally
(for localized excitation of the pro-drug) in order to initiate the pro-
duction of reactive species in situ. This yields a clearly defined focal area
of pale ischemic hepatic tissue, in which the organ parenchyma and
vasculature are affected by photodynamically-generated toxic species.
The same principle underlies photodynamic therapy (PDT), which can
be employed to target solid tumors [25] or microbial skin lesions [26].
In the latter approach, endotoxemic stress is induced by systemically
administering a non-lethal dose of lipopolysaccharide (LPS), which
elicits a temporary (up to 24 h) systemic endotoxemic shock in the
animals undergoing this procedure [27]. We used noninvasive organ
imaging of the live animals along with a detailed microscopic and
spectroscopic analysis of tissue specimens to assess the involvement of
redox-active transition metals and other paramagnetic species in liver
stress. First, abdominal ultrasound imaging (USG) was employed to
estimate the extent of ischemic damage in the hepatic parenchyma/
vasculature, further supported by measurements of the mean velocity
and computational 3D modelling of the liver vasculature. Then, (im-
muno)histological analysis of the tissue sections was used to char-
acterize those cell populations infiltrating the ischemic areas. Finally,
EPR spectroscopy and spin trapping were used to reveal the char-
acteristic “fingerprints” of the paramagnetic centers recorded in the
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injured and control livers.
2. Materials and methods
2.1. Materials
2.1.1. Animals
C57BL/6J mice (male, 7 weeks old) were purchased from the
Mossakowski Medical Research Center of the Polish Academy of
Sciences (Warsaw, Poland), or were obtained from the local animal
facility of the Faculty of Biochemistry, Biophysics and Biotechnology,
the Jagiellonian University (Kraków, Poland). The mice were kept in a
12/12 h light/dark cycle, with free access to food (standard laboratory
rodent chow) and water.
2.1.2. Photosensitizer
Zinc pheophorbide a (Zn-Pheide) was obtained as described pre-
viously [24,25,28,29]. Briefly, chlorophyll a was extracted from Spir-
ullina laporte and treated with chlorophyllase (EC No. 3.1.1.14) to re-
move the hydrophobic phytyl moiety [28]. The product was first
demetalated using glacial acetic acid and then metalated directly with
zinc acetate. After purification, Zn-Pheide was stored at −30°C under
Ar atmosphere. Zn-Pheide is a very potent singlet oxygen photo-
sensitizer, as indicated by our earlier in vitro and in vivo studies [24,25].
Owing to the presence of a central Zn ion, this photosensitizer produces
1O2 with a very high quantum yield of ~0.75. This is much higher ΦΔ
than those of the unmodified chlorophylls [30]. Our recent study [31]
has shed more light on the photochemical properties of Zn-Pheide: we
have shown that more than 90% of the first excited triplet state of this
photosensitizer yields 1O2. This translates into practically entire pho-
tosensitization via Type II reaction that is mediated by 1O2 [31];
therefore, in our system, free radicals (Type I reaction) are not expected
to be generated in any significant amounts.
2.1.3. Selected chemicals, drugs and antibodies
Accustain May-Grünwald stain, ammonium chloride, bovine serum
albumin (BSA), eosin Y, ferrous sulfate (FeSO4 × 7H2O), Giemsa stain,
lipopolysaccharide (LPS) from E. coli serotype O26:B6, sodium citrate
(C6H5Na3O7 × 2H2O), sodium diethyldithiocarbamate (C5H10NS2Na),
Sudan Black B, TAE buffer, TBS buffer, and Triton X-100 were pur-
chased from Sigma-Aldrich (St. Louis, US); ammonia water from POCh
(Gliwice, Poland); hematoxylin from Aqua-Med (Łódź, Poland); Aqua
Mount, Consul Mount, paraffin from Thermo (Waltham, US); Polysine
and Superfrost Slides from Gerhard Menzel GmbH (Brunswick,
Germany); Tween 20 from ICN Biomedicals (Irvine, US); ProLong
Diamond Antifade Mountant with DAPI from Fisher Scientific
(Loughborough, UK); streptavidin-HRP from Dako (Carpinteria, US);
DAB substrate peroxidase kit from Vector Laboratories (Burlingame,
US); isoflurane (AErrane) from Baxter Pharmaceutical Products
(Deerfield, US); ketamine (Bioketan) and xylazine (Sedazin) from
Vetoquinol Biowet (Puławy, Poland); medetomide hydrochloride
(Cepetor) from ScanVet (Gniezno, Poland); Aquasonic CLEAR ultra-
sound gel and SIGNAGEL electrode gel from Parker Laboratories
(Fairfield, US); and Veet depilatory cream from Reckitt Benckiser
(Nowy Dwór Mazowiecki, Poland). Primary and secondary antibodies
(Abs) used in this study are listed in Table 1.
3. Methods
3.1. Ethical aspects of the studies
The in vivo studies were carried out at the Jagiellonian University
(Kraków, Poland), and all the experimental procedures and approaches
were approved by the Local Ethical Committee for Animal
Experimentation (Kraków, Poland; decisions No. 46/2012 and 60–62/
2013), in accordance with EU Directive 2010/63/EU for animal
experiments. The animals received humane care and were allowed to
settle for two weeks before the experiments; the volumes of liquid ad-
ministered intraperitoneally (ip) did not exceed 0.5 ml, intravenously
(iv) 0.2 ml, and subcutaneously (sc) 0.05 ml.
3.2. Study design: photodynamic and endotoxemic models of liver stress
The experimental design and time scheme are summarized in Fig. 1.
The model of local photosensitizer-and-light-induced stress (PD-chal-
lenge) in a mouse liver was introduced in our previous work [24].
Briefly, the animals were treated with Zn-Pheide (2 mg/kg, iv) 70 min
before illumination with monochromatic 655 nm red light emitted by a
diode laser (Eurotek, Warsaw, Poland). Light was applied for 20 min at
a fluency of 100 mW/cm2, reaching a total light dose of 120 J/cm2.
Before illumination, the animals were anesthetized by ip application of
ketamine (8 mg/kg) and medetomide hydrochloride (0.1 mg/kg), then
the hair was removed from approximately 1 cm2 of their left thoracic
areas and the animals were placed on a 38°C-heating platform and il-
luminated. Untreated animals as well as the animals that received light
only- or Zn-Pheide only-treatment were used as the control groups.
Endotoxemic stress was induced by a single injection of lipopoly-
saccharide at a non-lethal dose (10 mg/kg, ip) which resulted in sys-
temic shock (LPS-challenge) [27].
3.3. Ultrasound imaging and mean velocity measurements
Noninvasive medical ultrasound imaging of the liver tissue was
carried out and the mean velocity in the hepatic vasculature was as-
sessed using a Vevo 2100 high-frequency, high-resolution digital ima-
ging platform (VisualSonics, Toronto, Canada). The data were collected
from the untreated control, and from the LPS- or PD-challenged ani-
mals, with n=3 mice per group. The animals were anesthetized with
isoflurane (2%, 0.5 L/min) and restrained on a 38°C-heating platform.
Their paws were covered with SIGNAGEL electrode gel and approxi-
mately 1 cm2 of their left thoracic areas were depilated using a cream.
The hair-free areas were then covered with Aquasonic CLEAR ultra-
sound gel, the ultrasound transducer was transferred to the 3D motor
stage and the 30 MHz respiratory-gated signals were collected from the
livers using a 3D-Mode imaging option. At the same time, a Power
Doppler Mode imaging option was used to register the mean velocity of
the blood; in parallel, the animal heartbeats were monitored using
electrocardiography. After imaging, the animals were humanely killed
by isoflurane overdose. All images were recorded digitally, and they
were analyzed using Vevo 2100 1.2.0 software and the methods de-
scribed below.
Table 1
Antibodies used for immunohistochemical studies.
Primary antibody Species Manufacturer (Catalog No.)
Anti-α-SMA Mouse monoclonal Abcam (7817)
Anti-CD45 Rat monoclonal Novus Biological (100-77417SS)
Anti-CD31 Rat BD Pharmingen (550274)
Anti-CD107b Rat BD Pharmingen (550292)
Secondary antibody Species Manufacturer (Catalog No.)
AlexaFluor 488 anti-rat Goat Fisher Scientific (10694383)
AlexaFluor 635 anti-mouse Goat Fisher Scientific (10413412)
Biotin anti-rat Ig Goat BD Pharmingen (559286)
Biotin anti-rat IgG1/2a Mouse BD Pharmingen (550325)
Abcam, Cambridge, UK; BD Pharmingen, San Jose, US; Novus Biologicals,
Cambridge, UK; Fisher Scientific (Loughborough, UK).
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3.4. Computational models of the liver vasculature
Original Vevo 2100 dmc files were converted to png files using
dcm2pnm 3.5.4 (Kuratorium OFFIS, Oldenburg, Germany), and then
the Python Image Library 1.1.7 (Secret Labs, Linköping, Sweden) was
used to process the images further, such as to crop them (remove the
outer parts of an image in order to improve framing), posterize (convert
a continuous gradation of tone to several regions of fewer tones) and
reduce the image color palette. The volume was visualized by proces-
sing the data with VolView 3.4 (Kitware, New York, US), and then the
3D models obtained were converted into a mesh format by Paraview
4.0.1 (Kitware, New York, US). The mesh-transformed models were
processed using MeshLab 1.2.2 (ISTI-CNR, Pisa, Italy): the noise, ori-
ginating from either the skin or thoracic diaphragm vasculature was
removed, the number of vertices (the points where two lines meet to
form an angle) was reduced and the unwanted boundary image fronts
deleted. Finally, Blender 2.67b (Stichting Blender Foundation,
Amsterdam, The Netherlands) was used to visualize the models.
3.5. Tissue analysis
Histology: The liver sections were stained using hematoxylin and
eosin (HE) and May-Grünwald-Giemsa (MGG) as described previously
[32].
Immunohistochemistry - DAB-HRP detection: The 6 μm frozen liver
sections were mounted on Superfrost glass slides, allowed to dry at
room temperature (RT; 1 h); then they were dehydrated in cold acetone
(10 min), dried again (RT; 30 min), and stored in phosphate-buffered
saline (PBS) at 4°C until further use for staining. The sections were
washed (5 min, ×2) in 0.04% Tween 20 in PBS (PBST) containing
0.025% Triton X-100, followed by blocking in 10% fat-free milk sup-
plemented with 1% bovine serum albumin (10 min), and then in egg
white (10 min). These and the following steps were carried out in a
humid chamber. Then the sections were incubated with primary rat
anti-mouse CD107b (0.6 μg/ml; 1 h) or rat anti-mouse CD31 (1.6 μg/
ml; 1 h) antibodies (Abs) prepared in PBST containing 0.025% Triton X-
100, and washed (5 min, ×2). The endogenous peroxidases were in-
hibited by 3% hydrogen peroxide (15 min); the sections were then
washed (3 min), incubated with secondary biotin mouse anti-rat
(2.5 μg/ml; 1 h) or biotin goat anti-rat (2.5 μg/ml; 1 h) Abs, and washed
(5 min, ×3). They were then incubated with streptavidin-conjugated
horseradish peroxidase (HRP, 30 min), washed (3 min), and incubated
with 3,3′-diaminobenzidine (2 min); Ni-enhancement was additionally
used for the CD107b staining. Chromogen development was stopped by
washing with tap water (5 min). The sections were counterstained in
Mayer's hematoxylin (3 min), washed with tap water (3 min) and in
0.2% ammonia water, and were sealed in Aqua-Mount mounting
medium. The tissue slides were inspected under a light microscope
Eclipse Ti (Nikon, Tokyo, Japan), photographed and analyzed. The list
of Abs used is given in Table 1.
Immunohistochemistry - fluorescence detection: The procedure was
performed as described previously [33]; the primary Abs were mouse
monoclonal anti-alpha-smooth muscle actin (α-SMA; 3.3 μg/ml; 1 h)
and rat monoclonal anti-CD45 (1 μg/ml; 1 h). The negative controls
were incubated in blocking buffer with no primary Abs. The secondary
Abs were AlexaFluor 635 goat anti-mouse (4 μg/ml; 1 h) and Alexa-
Fluor 488 goat anti-rat (4 μg/ml; 1 h), applied consecutively and se-
parated by washing. The tissue was preserved in antifade mounting
medium with DAPI. The slides were imaged using a two-photon TCS
SP5 II confocal microscope (Leica, Wetzlar, Germany), excitation wa-
velengths: 355, 488, 633 nm; laser power: 60, 15 and 4%, respectively;
resolution 512 × 512) and dry 20× HC PL FLUOTAR objective, and
were then stored at 4°C. The brightness and contrast in the confocal
images were adjusted using software supplied by the manufacturer. The
list of Abs used is given in Table 1.
3.6. Electron paramagnetic/spin resonance (EPR/ESR) measurements
Spin trap administration and sample preparation: Summary of the ex-
periments is presented in Fig. 1; the reagents were prepared according
to the protocols described previously [27]. The spin trap was ad-
ministered to all experimental animals (with exception of the “No spin
trap” group) in a classical two-step fashion [34–37]. First, mice re-
ceived (i) a single ip injection of DETC (500 mg/kg), and then (ii) a
subsequent sc injection of chelated iron(II) complexes of ferrous sulfate
together with sodium citrate (50 mg/kg and 250 mg/kg, respectively)
into the scruff of the neck [36]. This intentional spatial separation of
spin trap components - at the moment of injection - prevented an in-
soluble precipitate from being formed in the animal cavity fluids
[34–36,38]. By adopting this strategy in our experiments, we provided
means of the efficient and safe spin trap delivery. 30 min after the
administration of both spin trap components, they had fully combined,
yielding an active spin trap in the animal organs/blood [27]. The mice
were then deeply anesthetized (ketamine and xylazine, 150 mg/kg and
10 mg/kg, ip) and the blood was collected from the beating hearts. The
livers were then dissected, photographed and the edge parts of lobus
hepatis sinister lateralis, along with blood aliquots, were snap frozen in
liquid nitrogen in 2 cm long glass tubes (inner diameter 0.4 cm), and
then were stored at −80°C until spectroscopic analysis [24].
EPR spectroscopy: The samples were measured at 77 K in a cold
finger quartz Dewar using an EPR X-band (ca. 9.4 GHz) spectrometer
EMX (Bruker BioSpin, Rheinstetten, Germany). The following para-
meters were applied: field 333.5 ± 25 mT (signals from the g = 2.0
region) or 133.5 ± 60 mT (signals from the g = 4.3 or g = 6.0
Fig. 1. Two models of liver stress - summary of the
experiments. C57BL/6J mice were challenged either
phodynamically or endotoxemically (PD- or LPS-
challenge, respectively), or remained unchallenged
(controls). Left schemes show the treatment. PD-
challenge: Mice received iv injections of a light-acti-
vated pro-drug Zn-Pheide and were then illuminated
with red light; and LPS-challenge: Mice received ip
injections of LPS. Right schemes show data acquisi-
tion. EPR spin trapping: Mice received ip injections of
DETC and subsequent sc injections of Fe(II) com-
plexes (forming together the EPR spin traps). Then
the mice were humanely killed, and the blood and
the liver samples were collected; the livers were ei-
ther fixed for (immuno)histological analysis, or were
snap frozen in liquid nitrogen along with the blood samples, and EPR spectra of the samples were recorded; USG-Doppler analysis:Mice received isoflurane inhalation
(anesthetic) and anatomical images of the liver tissue along with the mean velocity maps were recorded. Black solid lines: continuous time scale [h]; grey solid lines:
time scales [h] 2–72 for PD- and 2–6 for LPS-challenge groups, respectively; grey dashed lines: transitions from treatment to data acquisition; filled circles (•):
injection/inhalation points; and multiplication signs (×): experimental end-points.
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regions), modulation amplitude 0.5 mT, conversion time 40.96 ms,
time constant 20.48 ms, microwave power 4.2 mW, receiver gain
1 × 104 (liver) or 1 × 103 (blood), and resolution 1024 points. A total
number of 16 scans were accumulated in each spectrum. The spectra
were analyzed using WinEPR software (Bruker BioSpin, Rheinstetten,
Germany) and Eleana 0.9.8, free software developed by Dr. Marcin
Sarewicz and other contributors (Department of Molecular Biophysics,
the Jagiellonian University, Kraków, Poland; see https://eleana.larida.
pl/). Eleana software offers a “Read position” mode that returns an
exact g value for any magnetic induction of interest within the mea-
sured range. We used this software function to read the analytical g
values, and then, on the basis of the literature data, to identify the
paramagnetic components in the liver and blood spectra. The char-
acteristics of the measured EPR signals along with the references are
summarized in Table 2.
3.7. Statistical analysis
The quantitative results were presented as the mean ± standard
error of the mean (SEM). For the statistical analysis, the Mann-Whitney
U test was used, and the p values < 0.05 were considered significant.
4. Results
Two experimental models of photodynamically- or endotoxin-in-
duced stress in the mouse liver (PD- or LPS-challenge, respectively;
Fig. 1) were studied, in which blood flow (Fig. 2), tissue morphology
(Figs. 2–4), protein expression (Figs. 3 and 4), and EPR signals
(Figs. 5–8) were analyzed. Importantly, no symptoms of challenge-in-
duced jaundice (such as a yellow-coloration of the skin, mouth or
mucous membranes) were found in either the control or the experi-
mental animals (not shown); no color changes in the urine/feces were
present. This confirms that in these livers at least some parts maintained
their physiological functions, including the production and secretion of
bile.
4.1. Photodynamic but not endotoxin challenge affects the liver tissue and
reduces blood flow in hepatic vasculature
We first analyzed the liver tissue and hepatic vasculature using the
non-invasive methods of small-animal imaging. The ultrasound ex-
amination (USG) along with an assessment of the mean velocity (speed
of blood flow) in this organ revealed the differences between the PD- or
LPS-challenged versus control mice (Fig. 2). The black and white ana-
tomical images demonstrated the presence of areas of high echogenicity
(depicted in light greys in the image) in the livers of PD-challenged
mice (Fig. 2A). Such areas were neither detected in the control livers
(Fig. 2A) nor in the LPS-challenged animals (not shown). Color-coded
mean velocity maps showed a decrease in the number of blood vessels
in PD-challenged livers (Fig. 2A; white triangles). Yellow was used to
indicate the highest, and red - the lowest speed of blood flow. Also, the
impaired hepatic blood flow, reflected in a low content of yellow/or-
ange, was observed in the PD-challenged mice (Fig. 2A). In contrast, no
significant velocity changes (such as decreased speed of blood flow and
resulting perfusion abnormalities) were revealed in the livers of the
LPS-challenged animals. The 3D computational models of the liver
vasculature in the control, LPS- or PD-challenged mice (Fig. 2B; upper,
middle and bottom models, respectively) showed differences in the
hepatic vasculature even more clearly, which was supported by a fur-
ther analysis of the vascular volume (Fig. 2C). 3D modelling analysis
confirmed a ~75% reduction in the liver vascular volume in PD-chal-
lenged animals (cream bar), compared to the control (orange bar).
4.2. Photodynamic challenge in the liver leads to necrotic tissue damage
Then we characterized liver tissue by (immuno)histological ana-
lysis. Paraffin-embedded tissue samples of all experimental animals and
frozen liver tissue samples of PD-challenged mice, were examined in
detail (Fig. 3). Histological staining methods, i.e. hematoxylin & eosin
(HE; Fig. 3A, C, E, G) and May-Grünwald-Giemsa (MGG; Fig. 3B, D, F,
H), demonstrated the presence of necrotic areas of the liver parenchyma
solely in PD-challenged mice (Fig. 3E–H; see also macrophotographs
Fig. 3I–J). These necrotic areas were distinguished from normal parts
by their distinctive discoloration (pale yellow color instead of brown
native to the liver) and were later identified as being of a purely is-
chemic nature. Ischemic tissue contained predominantly dead hepato-
cytes of “translucent” appearance and they stained uniformly with
eosin, owing to the dissolution of nuclei and loss of intercellular borders
(Fig. 3E). The necrotic zones, as seen in the staining (Fig. 3G–H; red
arrows), were infiltrated by mononuclear leukocytes of various types;
the presence of extravasated blood was also detected in the necrotic
liver parenchyma (Fig. 3E–H; blue arrows). Further im-
munohistochemical staining for the endothelial marker CD31 was car-
ried out to compare the lumen patterns (vascular, not ductal) in the
normal versus necrotic tissue parts of the PD-challenged livers (Fig. 3K-
L; yellow arrows). While the normal hepatic parenchyma contained
fully functional blood vessels (Fig. 3K), collapsed vessels in the ischemic
parts (Fig. 3L) were surrounded by a prominent tissue scar, and were
unable to transport blood effectively (see also Fig. 2B–C). The bound-
aries between the normal and ischemic tissues were infiltrated by the
CD107b-expressing mononuclear phagocytotic cells (Fig. 3M; red ar-
rows), likely the macrophages.
4.3. Photodynamically challenged liver contains areas of intensive reactive
and regenerative processes
In order to provide further insights into cellular components of the
PD-challenged livers, we used confocal microscopy and fluorochrome-
Table 2
Characteristics of the EPR (ESR) signals measured - a summary of the literature data.
Paramagnetic signal g-factor literature value HFS (analytical lines) References
LIVER
NO–FeII-(DETC)2 Iron(II) diethyldithiocarbamate complexes 2.035 Triplet (III) [36,59,65]
CuII(DETC)2 Copper(II) diethydithiocarbamate complexes 2.025 Quarter (III) [36,61]
Semiquinone Semiquinone free radical* 2.004 – [65]
Mo(V) Molybdenum(V)* 1.97 – [66]
Fe–S The reduced Riske cluster* 1.94 – [59,66–68]
BLOOD
MetHb Methemoglobin 6.0 – [63,67]
FeIII-TF Transferrin-bound iron(III) 4.3 – [59,63]
CuII(DETC)2 Copper(II) diethyldithiocarbamate complexes 2.025 Quarter (III, IV) [36,61]
HbNO Nitrosylhemoglobin 2.012 Triplet (I, III) [69–71]
EPR(ESR), electron paramagnetic (spin) resonance; HFS, hyperfine structure; I, II, etc., lines I, II, etc. (low to high-field) of the hyperfine structure; *these are the co-
factors of xanthine oxidase [72].
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conjugated antibodies (Fig. 4). The cells present in the scar tissue be-
tween the normal and ischemic zones were probed simultaneously for
the presence of the pan-leukocyte marker CD45 (Fig. 4A, C, E-F) and the
myofibroblast-like cell marker α-smooth muscle actin (α-SMA) (Fig. 4A,
D, F-G). The nuclei were counterstained with DAPI (Fig. 4A–B, E, G).
The CD45-expressing cells infiltrated mainly the areas adjacent to the
blood vessels, but were also scattered in the scar tissue, including its
edges (Fig. 4A, C, E-F). The α-SMA-expressing cells, likely hepatic
stellate cells [39], could only be found in the areas of insult, in which
they formed a discrete network of elongated cells spreading toward the
ischemic tissue (Fig. 4A, D, F-G). The presence of CD45- or α-SMA-
expressing cells, respectively, indicated the dynamic nature of the re-
active (here: inflammatory) or regenerative processes (fibrosis devel-
opment) in the boundaries between the necrotic and live areas of the
tissue in the close vicinity of blood vessels.
4.4. Stress affects the EPR spectra of transition metal complexes in situ
We used EPR spectroscopy to analyse the snap-frozen liver or blood
samples at 77 K, which detects paramagnetic species, including metal
complexes in biological samples. This analysis revealed differences in
the in situ signals recorded in liver and whole blood samples (Fig. 5; see
also Table 2). The EPR spectra of the intact (the “No spin trap” group of
mice that is free from any exogenous spin trap) control samples of both
liver and blood (Fig. 5A) showed paramagnetic components like those
of the semiquinone, molybdenum(V) or reduced iron-sulfur clusters,
whereas the blood samples also showed the presence of NO-hemoglobin
adduct (nitrosylhemoglobin, HbNO). The HbNO signal contained a
component of a narrow triplet hyperfine structure (HFS; blue marker).
To detect free radicals in other liver and blood samples, the FeII-DETC
complexes were used as exogenous spin traps (Fig. 5B–F). Compared to
the intact control (Fig. 5A, left), the FeII-DETC complexes did not re-
shape the spectra recorded in the vehicle (Fig. 5B, left), vehicle and
light (Fig. 5C, left) and Zn-Pheide and no-light (Fig. 5D, left) control
liver groups. Interestingly, in the blood samples collected from these
groups of animals, a background signal of CuII(DETC)2 complexes that
contained a component of a quarter HFS was found (Fig. 5B–D, right;
red marker). In the blood samples, the CuII(DETC)2 HFS (red pointers,
line III) partially overlapped with the HbNO HFS (blue pointers, line II).
The normal part of the PD-challenged livers (Fig. 5E, left; black solid
line) revealed spectral characteristics similar to those of the controls
(Fig. 5B–D). This was in sharp contrast to the ischemic part of the PD-
challenged livers (Fig. 5E, left; grey solid line) in which all typical
paramagnetic components of the liver spectrum (the semiquinone free
radical, Mo(V) or reduced iron-sulfur clusters), but a marked CuII
(DETC)2 signal, were absent. Since CuII(DETC)2 was the only EPR-de-
tectable species, this indicates a dramatic change in the paramagnetic
centers of the liver tissue that become EPR-silent (quenched). In gen-
eral, the CuII(DETC)2 signals in the blood were of a much lower am-
plitude, and the EPR spectrum did not change upon PD-challenge
(Fig. 5E, right), whereas endotoxemic stress changed both the liver and
blood EPR patterns (Fig. 5F). Their spectra contained typical EPR sig-
nals of paramagnetic NO–FeII(DETC)2 complexes of a narrow triplet
HFS (green marker), which confirms NO production. Therefore, in our
experimental settings, LPS-challenge also provides a positive control for
photodynamically stressed livers.
4.5. Stress affects NO level in the liver and blood
We investigated the presence of NO in the liver and blood samples
by EPR spin trapping in the form of stable paramagnetic spin NO ad-
ducts (Fig. 6). FeII-DETC complexes and hemoglobin served as exo-
genous and endogenous NO spin traps, respectively. A significant in-
crease in the NO levels (p = 0.008), as compared to the control, was
observed in the livers after LPS challenge (see variations at the ampli-
tude of NO–FeII(DETC)2 signals; line III, Figs. 5F and 6A). In contrast,
Fig. 2. Photodynamically-induced stress affects
the liver vasculature and blood flow. A
Representative sagittal plane images of the con-
trol (left) and PD-challenged (right) livers. The
series of liver images were collected in a 3D-
imaging mode (black and white anatomical
images) combined with a Power Doppler mode
(color-coded mean velocity maps, in which
yellow represents the highest and red the lowest
speed of blood flow). A: anterior (the front); and
P: posterior (the back) of an animal; white tri-
angles: blood vessels, n=3 mice per group. B
Representative 3D-reconstruction images of the
liver vasculature - computational models of the
control (upper), LPS-challenged (middle) and
PD-challenged (bottom) livers. Blue line: sagittal
axis; green lines: frontal axes. C Functional vas-
culature volume of the control (orange), LPS-
challenged (yellow) and PD-challenged (cream)
livers. n=3 mice per group, results presented as
the mean % ± SEM.
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Fig. 3. Photodynamically-induced
stress causes ischemic necrosis in the
liver. Control (A-B), LPS-challenged
(C-D) and PD-challenged (E-H) livers
were stained using hematoxylin and
eosin (A, C, E, G) or May-Grünwald-
Giemsa (B, D, F, H) staining methods;
paraffin-embedded tissue slices, ori-
ginal magnification: 100×, brightness
and contrast improved. A-B Control
tissues show normal hepatic mor-
phology. C-D LPS-challenged livers
show similar morphology to the con-
trol. E-F PD-challenged livers contain
both the areas of normal tissue (left
corners purple/dark blue) and the
areas of ischemic necrosis (right cor-
ners pale pink/light blue); leukocyte
infiltration can be seen at the border
between these areas. Blue arrows
show the presence of extravasated
blood. G-H Expanded areas shown in
E-F with dashed-line rectangles. An
islet of ischemic tissue surrounded by
normal tissue (G) and the area around
a collapsed blood vessel (H; see also
Fig. 3L); original magnification:
120×. Blue arrows: extravasated
blood; red arrows: leukocyte infiltra-
tion. I-J Macro photographs of PD-
challenged livers. Yellow color in-
dicates ischemic necrosis. Scale: 1 cm.
K-M PD-challenged livers were stained
immunohistochemically using anti-
CD31 (K-L) or anti-CD107b (M) anti-
bodies; frozen tissue slices, DAB-HRP
staining (with Ni signal-enhancement
in M), nuclei counterstained with he-
matoxylin, original magnification:
120×, brightness and contrast im-
proved. K-L Vascular protein CD31
visualized in the normal (K) and the
collapsed blood vessels (L; see also
Fig. 3H) of a PD-challenged liver.
Yellow arrows: staining (brown) of
CD31. M CD107b protein, expressed
by mononuclear phagocytes, is visua-
lized in the tissue surrounding two
non-collapsed blood vessels in the is-
chemic part of a PD-challenged liver.
Red arrows show the staining (dark
brown to black) of the CD107b-posi-
tive immune cells infiltrating the
tissue.
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the PD-challenge dramatically decreased (p = 0.003) the NO levels in
the ischemic part of the liver (filled circles), but it did not affect the
normal part (empty circles) of this organ (Fig. 6A). Amplitudes of the
NO–FeII(DETC)2 signals were also assessed in the blood samples
(Fig. 6B), where a significant increase in NO levels (p = 0.012) was
found solely in LPS-challenged animals. Analysis of hemoglobin-
trapped (HbNO), and thus “bio-available” NO, confirmed an elevation
in its level in the blood (line I, empty squares; and line III, filled squares
in Fig. 6C; see also Fig. 5). Again, LPS-challenged animals had higher
blood NO levels than mice in other experimental groups.
4.6. Paramagnetic Cu content soars in the liver upon photodynamic
challenge
Analyzing paramagnetic Cu complexes in the liver and blood shows
that only the ischemic livers were the source of the Cu(II) spin adduct to
DETC, CuII(DETC)2 (Fig. 7A; see also Fig. 5, left). Unlike any other
analyzed liver tissue (empty circles, Fig. 7A), an increase in the Cu(II)
signal (amplitude of line III; filled circles, Fig. 7A) in the ischemic PD-
challenged liver was significant (p = 0.002). In the blood samples, the
CuII(DETC)2 signals had similar levels in all experimental groups (am-
plitudes of line III, filled squares; and line IV, empty squares Fig. 7B).
4.7. Stress induces elevations in liver and blood paramagnetic Fe species
We used EPR spectroscopy to detect the paramagnetic Fe complexes
in the liver and blood samples. Reduced Riske cluster (Fe–S) EPR sig-
nals were present in all but the ischemic parts of the PD-challenged
livers (filled circles, Fig. 8A). The drop in the Fe–S signal was significant
(p = 0.002) as compared to the normal part of the PD-challenged livers
or controls (empty circles, Fig. 8A). Similarly to the Fe–S signals, the
EPR spectroscopic signals of Mo(V) were absent in the ischemic parts of
the PD-challenged livers (not shown). Other paramagnetic Fe species,
such as Fe(III) in methemoglobin (MetHb), or transferin-bound Fe (TF),
were also seen in the blood (Fig. 8B–C). Elevated MetHb levels were
detected in the blood samples collected from animals that had under-
gone PD/LPS challenge, but not in control animals (Fig. 8B). However,
in blood samples from the control and PD-challenged mice the FeIII-TF
levels were similar and slightly decreased in LPS-challenged animals
(Fig. 8C).
5. Discussion and conclusions
Although micronutrients such as Cu, Fe and others have long been
acknowledged to be redox cofactors in fundamental physiological re-
actions, biologists tend to perceive them merely as elements of in-
organic chemistry. Nevertheless, recent extensive studies on these me-
tals in cells and tissues provide new insights into the roles of redox-
active trace elements in physiological and pathological processes.
However, understanding of the actual involvement of transition metal
ions accumulated in the body (and hence potentially harmful) in the
mechanisms of pathology is still very limited. Since Fe ions have re-
cently been identified as the regulators of ferroptosis (a unique non-
apoptotic cell death) [12] it may be anticipated that further studies will
also reveal the roles of other transition metals in a variety of biological
processes [6]. For example, Cu may modulate the function of synaptic
receptors and channels, being also implicated in severe neurodegen-
erative disorders [6,40]. Significantly, disruption in tissue copper
homeostasis, which has been studied in mice with Cu transporter
Fig. 4. The boundaries between the scar and normal tissue are the areas of
intensive reactive and regenerative processes. A PD-challenged livers were
stained immunohistochemically using anti-CD45 (green) together with anti-α-
SMA (red) antibodies; paraffin-embedded tissue sections, nuclei counterstained
with DAPI (blue), original magnification: 20× , scale bar: 100 μm, brightness
and contrast improved. B-D Single channel-components of an image A; nuclei
stained with DAPI; blue (B), the pan-leukocyte protein CD45-expressing cells
infiltrate the scar; green (C), and the α-SMA-expressing mesenchymal cells form
the network that surrounds a non-collapsed blood vessel, spreading toward the
necrotic tissue; red (D). E-G each overlays two channels shown in B-D; blue and
green (E), green and red (F), and blue and red (G). B-G scale bar: 100 μm. See
also Fig. 3H, L-M.
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cardiac-specific knockout, may be communicated across organ systems
[41,42]. In these knockout animals a “low Cu” signal carried from the
heart via blood serum mobilized Cu from its hepatic and intestinal
supply. Also, other studies have shown that both Cu and Fe levels in-
crease in the case of post-ischemic heart injury [43]. In the light of
these findings, the subject of this study - determining whether under
pathological conditions redox-active transition metals are recruited
from the liver (a key organ for storing Cu and Fe) to the blood - is of
particular importance. However, photodynamic challenge, but not LPS
administration, affect hepatic vasculature, leading to ischemic necrosis
in the liver parenchyma, as evidenced by ultrasound examination, 3D
computational modelling (Fig. 2), and histological staining (Fig. 3),
respectively. This has prompted us to extend our study and investigate
the putative involvement of nutritional transition elements in the pro-
cesses that drive liver necrotization under a limited supply of O2 (and
thus a lower probability of electron exchange with O2). The develop-
ment of necrotic damage in this organ, as a result of local photo-
sensitization (treatment with a light-activated pro-drug in the presence
of light), has been previously reported by us [24] and others [44,45].
These studies, however, have not provided spectroscopic or (immuno)
histological insights into the nature of hepatic necrosis, which is of
potential clinical relevance, e.g. in liver transplantation. The present
study demonstrates not only that PD-challenge reduces blood supply to
the tissue (Fig. 2; see also Fig. 3H, K-L), but also delivers a detailed
Fig. 5. Both photodynamic and en-
dotoxemic stress impact the liver free
radical spectral profiles. Representative
EPR spectra recorded in situ in the liver
(left) and whole blood (right) samples
collected from the control (A-D) or the
challenged (E-F) animals. A Spectra of
spin trap-free samples. B–F FeII-DETC
complexes served as the exogenous spin
traps in the vehicle (B), vehicle and
light (C) and Zn-Pheide and no light (D)
control groups; and in the photo-
dynamically (E) or endotoxemically-
challenged (F) groups; scale: 5 × 107
(left) and 1 × 106 (right), normalized
amplitude [a.u./g]. Thick black dotted
lines: center of the magnetic field, at
g = 2.0; thin black dotted lines (left to
right): molybdenum(V) and reduced
iron-sulfur cluster signals in the liver;
black solid lines: normal liver/blood
spectra; grey solid line: ischemic liver
spectrum; dotted/solid horizontal lines
with the arrows - the hyperfine struc-
ture (HFS) markers: α5NO, blue,
NO–FeII(DETC)2, red, and CuII(DETC)2,
green; note that the thick solid arrows
indicate the analytical amplitudes. See
also Table 2.
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description of the cellular components of the necrotic liver (Figs. 3 and
4). It is noteworthy that histological analysis of the septic liver,
achieved by a non-lethal dose of LPS administered 24 h before the
sample collection, did not reveal any differences from the control tis-
sues (Fig. 3A–D), whereas PD-challenge resulted in the development of
the foci of hypoperfused tissue (Fig. 3E–J). Further analyses of the
necrotic tissue confirmed the presence of live cell populations close to
the hollow cavities (lumens of blood vessels or ducts). Via the expres-
sion of CD31 (Fig. 3L) in the endothelium, these have been identified as
blood vessels (ductal epithelium lacks CD31 expression) [46,47]. This
resembles a typical liver regeneration pattern outlined by intensive
processes of tissue restoration, as performed by the cells that fuel a
desmoplastic reaction and reactive processes, as driven by immune cells
(Fig. 3G–H, M and Fig. 4), both processes being confined to vessels/
ducts [48]. CD107b-positive mononuclear phagocytes, likely macro-
phages, were found in necrotic areas in the vicinity of blood vessels
(Fig. 3M). Importantly, macrophages have commonly been acknowl-
edged for their regulatory role in systemic Fe homeostasis [49].
Therefore, the abundance of them in the PD-challenged tissue may be
attracted by Fe-rich dead cells, such as erythrocytes from the extra-
vasated blood, or hepatocytes (Fig. 3G–H). By removing cell debris,
macrophages prevent Fe depletion and maintain its homeostasis. The
presence of other immune cells, the CD45-positive leukocytes, in close
proximity to the α-SMA-expressing cells, is probably caused by a des-
moplastic reaction that secures tissue integrity in the injured organ
(Fig. 4). The α-SMA-positive cells, likely hepatic stellate cells (HSCs)
[39], produce extracellular fibers to restore tissue mechanostasis and
thus provide advantageous conditions for liver regeneration [50]. No-
tably, the processes of HSC activation and production of the fibrous
matrix may become accelerated by Fe overload-induced oxidant stress
[14]. Furthermore, complex tissue-healing processes (especially in their
early phases) may be facilitated via the production of NO by infiltrating
immune cells (e.g. macrophages) and stellate cells [33,51,52]. We
therefore attempted to determine the plausible involvement of NO in
the processes ongoing in the PD-challenged livers, and compare these
processes to those observed in the LPS-challenged organ [27,53]. In our
experimental strategy of NO-spin trapping we have implemented re-
commendations of Vanin and Kleschyov [35], who gave the DETC-in-
jected animals exogenous Fe. Noteworthy, the same authors reported
that even the physiological amount of Fe(II) in mouse body fluids is
sufficient to form Fe-DETC complexes fully capable of NO trapping
[35]. This also means that an experimental group receiving DETC only
(no exogenous Fe(II) supplementation; not examined in our study)
would still be able to generate an active form of the spin trap, although
to a lesser extent, using the endogenous Fe(II) pool [34,35]. In a form of
such complexes, NO has been detected by EPR spectroscopy at liquid
nitrogen temperatures. One of the main advantages of this method is its
excellent specificity in detecting the paramagnetic species, including
certain transition metal ions present in the biological samples [54].
Indeed, the liver and blood EPR spectra contain components originating
from transition metal ions/complexes. These included copper(II) die-
thyldithiocarbamate complexes, CuII(DETC)2; molybdenum(V), and the
reduced Riske cluster, Fe–S, in the liver along with methemoglobin,
MetHb; transferrin-bound iron(III), FeIII-TF; copper(II) diethyldithio-
carbamate complexes, CuII(DETC)2, and nitrosylhemoglobin, HbNO, in
the blood (Fig. 5 and Table 2). The EPR spectra of all the control livers
and necrosis-free parts of the PD-challenged organs are similar
(Fig. 5A–E) while those of the necrotic livers (Fig. 5E) contain a marked
component of the CuII(DETC)2 signal, lacking virtually all other EPR
signals that are normally seen in this organ. Notably, these dramatic
differences occur within the same organ between sections harvested
from its live and dead zones (Fig. 5E; see also Figs. 7A and 8A). Im-
portantly, diethyldithiocarbamate used here as a spin trap has a potent
copper-chelating capacity [55], yielding Cu(II)-DETC complexes that
are more stable than other DETC complexes with divalent metal ions,
for example Fe(II) [56]. This strong affinity of DETC for Cu opens up a
potential therapeutic avenue for Menkes syndrome (neurodegenerative
Cu deficiency). Patients suffering from this disorder could be given CuII
(DETC)2 complexes orally in order to increase their Cu levels towards
more physiological values [55]. Other EPR signals of paramagnetic
DETC complexes, NO–FeII(DETC)2 (Fig. 5F), characterized by a narrow
Fig. 6. Elevated liver and blood nitric oxide levels are both associated with
stress. A-C Normalized amplitudes [a.u./g] of the EPR signals recorded in the
liver (A) and whole blood (B–C) samples collected from the control (DETC,
Light and Zn-Pheide) or the challenged (PD and LPS) animals. Results are
presented as individual data points and the mean ± SEM; p values (the Mann-
Whitney U test) indicate significant differences between the groups. A
Amplitudes of NO–FeII(DETC)2 signals, line III, in the normal (empty circles) or
ischemic (filled circles) liver tissue. Break: 5.7 ÷ 7.0. B Amplitudes of NO–FeII
(DETC)2 signals, line III, in the blood. C Amplitudes of HbNO signals, line I
(empty squares) and line III (filled squares), in the blood.
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triplet hyperfine structure, were detected clearly in LPS-challenged
liver (p = 0.008 vs control) and blood (p = 0.012 vs control) samples,
but not in other groups (Fig. 6A–B). Similarly, the signal from another
paramagnetic NO adduct, HbNO, was elevated solely in the blood col-
lected from endotoxemic animals (Fig. 6C). According to the historic
dogma, HbNO had been a hallmark of necrosis: NO released by in-
flammatory cells infiltrating the necrotic tissue is trapped by he-
moglobin form extravasated blood, yielding HbNO [57,58]. The ab-
sence of HbNO signal in the EPR spectra of necrotic liver (Fig. 5E) might
be explained by the ischemic (shortage of blood) and not hemorrhagic
(massive blood extravasation) character of necrosis. Further, in terms of
NO content, the ischemic liver contained much less NO–FeII(DETC)2
than the non-necrotic liver zones (p = 0.003; Fig. 6A), despite the
ongoing reactive/regenerative processes (Figs. 3 and 4). This may be
explained by the rather modest live/necrotic cell ratio in this tissue.
Finally, the reduced Riske cluster signals in necrotic tissue were almost
undetectable (p = 0.002 vs control/normal part of a PD-challenged
liver, Fig. 8A). Taken together, our results indicate that at least some of
the physiologically paramagnetic species (detectable by EPR spectro-
scopy) undergo redox reactions during ischemia development, yielding
diamagnetic (EPR-silent) species, or a mix of those. Another possible
reason is the lack of endogenous reductants in the ischemic tissue which
could convert the diamagnetic NO–FeIII-(DETC)2 adducts into para-
magnetic NO–FeII-(DETC)2 ones [59]. This, however, does not explain
the presence of strong CuII(DETC)2 signals (p = 0.002 vs other samples,
regardless of the treatment) in the ischemic zones (Figs. 5E and 7A). A
strong Cu(II) signal in the EPR spectra of ischemic livers may originate
from a photodynamic Cu oxidation in situ in metal-storing liver cells
(hepatocytes and others) as opposed to ischemia-elicited interconver-
sion of intrinsic hepatic Cu(I), bound to copper chaperones, to Cu(II).
Under physiological conditions, cooper ions predominantly exist as
diamagnetic (EPR-silent) Cu(I) [3,54,60], and in pathophysiological
conditions may be further oxidized to Cu(II). Copper(II) is then com-
plexed with a spin trap, yielding a paramagnetic species CuII(DETC)2 of
a very high stability, much higher than this of FeII-(DETC)2 [56]. Those
Cu complexes are easily detectable by EPR spectroscopy, especially in a
hydrophobic membrane environment [61]. Importantly, due to the
catalytic activity of Cu(II) harmful lipid-based radicals may be pro-
duced in the body [11], and indeed Cu(II)-loading has been reported to
worsen post-ischemic injury of the heart [62]. As such, in order to
prevent exacerbation of Cu-mediated radical reactions, Cu(II), upon
being delivered to the target tissue, needs to be either reduced back to
Cu(I) and transported to target proteins [3], or removed from the body.
Since Cu is transported within the body as Cu(II), the presence of CuII
(DETC)2 may enhance copper excretion with bile, which is a typical
means of copper clearance [3–5]. Additionally, only a modest increase
in Cu(II) levels in the blood (Figs. 5 and 6B) indicates a lack of Cu
recruitment across the body from its hepatic store, pointing towards its
reduction back to Cu(I) and/or excretion with bile. However, analytical
measurements of biliary Cu (as well as other transition elements) are
out of the scope of this study. It needs to be acknowledged, however,
that the use of a spin trap DETC makes it impossible to detect a serum
Cu-transporting protein ceruloplasmin (CP) using EPR. By contrast, in
DETC-free samples, CP can be easily detected by EPR owing to its broad
singlet signal at g = 2.05. Importantly, CP level soars in severe in-
flammatory processes that underlie the septic shock or advanced stages
of cancer, and EPR is an appropriate method for studying these rises in
CP. Nevertheless, our earlier studies on blood samples (DETC-free)
collected from the mice that received Zn-Pheide and light therapy to the
lung xenograft tumors or PD-stress to the liver, revealed no changes in
CP levels upon the photodynamic treatment [24]. Therefore, in this
study, we did not focus on studying CP in the blood.
Nevertheless, apart from the elevated NO levels (Fig. 6B–C), at least
a few spectral “fingerprints” of stress have been assessed in blood
samples. First, increases in methemoglobin content, pointing toward
the oxidation of heme iron into Fe(III), have been detected in blood
samples collected from the PD- or LPS-challenged animals (Fig. 8B). A
similar elevation in MetHb upon stress, also assessed using EPR spec-
troscopy, has been reported in human subjects, who having worked in
1986 as liquidators of the Chernobyl disaster, became exposed to low-
intensity radiation [63]. Another stress-related change in the para-
magnetic “landscape” of the blood spectra analyzed is a decrease in
transferrin-bound iron(III) in endotoxemic animals (Figs. 5 and 8C).
This notion is in line with the findings of so called “anemia of in-
flammation” - which is essentially limited Fe availability upon infection
that acts to decrease microbial pathogenicity [64]. Anemia of in-
flammation also occurs in neoplastic diseases, and this may explain
decreases in FeIII-TF in the blood of the liquidators mentioned above
who likely developed neoplasia as a result of exposure to radiation
[63].
Taken together, here we establish a new model of hepatic ischemia.
The model of ischemic induction proposed by us is relatively easy to
Fig. 7. The copper(II) content is substantially higher in the ischemic tissue compared to the normal liver. Normalized amplitudes [a.u./g] of the EPR signals recorded
in the liver (A) and whole blood (B) samples collected from the control (DETC, Light and Zn-Pheide) or the challenged (PD and LPS) animals. Results presented as
individual data points and/or the mean ± SEM; p values (the Mann-Whitney U test) indicate significant differences between the groups. A Amplitudes of CuII
(DETC)2 signals in the normal (empty circles) or ischemic (filled circles) liver tissue. Break: 0.25 ÷ 7.0. B Amplitudes of CuII(DETC)2 signals in the blood; line III
(filled squares) and line IV (empty squares). Break: 3.3 ÷ 4.1.
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achieve - it neither requires specialist training, nor complicated pro-
cedures or advanced equipment. Even more importantly, the model
involves only minimal animal distress as compared to the surgical
models. In our model, we show that on the cellular and sub-cellular
levels ischemic liver tissue differs dramatically from normal hepatic
parenchyma, as confirmed by microscopic and spectroscopic techni-
ques. On the basis of EPR measurements, we also hypothesize about the
role that redox-active transition metals play in liver health and patho-
physiology. These results are important for an understanding of the
processes that drive the development of liver necrosis, which is very
relevant to organ transplantation and injury.
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